Form DEFA14A Skye Bioscience, Inc.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(RULE 14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant x
Filed by a Party other than the Registrant o
Check the appropriate box:
o
Preliminary Proxy Statement
o
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o
Definitive Proxy Statement
x
Definitive Additional Materials
o
Soliciting Material Pursuant to §240.14a-12
SKYE BIOSCIENCE, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
x
No fee required.
o
Fee paid previously with preliminary materials.
o
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- $9.9 Million Revenue for First Half of 2026, a 25% Increase Over Same Period in 2025 for Emerging AI and Robotics Developer Baird Medical Investment Holdings (Nasdaq: BDMD)
- easyspecs.ai launches a spec review platform so engineering teams can trust AI-generated code nobody has time to read
- Cardano Price Prediction: Can ADA Rip to $0.30? DigiTap Starts at $0.0589 Before Its Public-Market Run Even Begins
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
